Description

Femoston Conti (estradiol) Coated Tablets 1 mg/5 mg. №28

Ingredients

Each tablet contains 1 mg of estradiol and 5 mg of dydrogesterone.

Dosage

The usual dose is one tablet daily. It is important to follow the instructions provided by your healthcare provider.

Indications

Femoston Conti tablets are indicated for hormone replacement therapy in postmenopausal women. They help relieve symptoms associated with menopause, such as hot flashes and vaginal dryness.

Contraindications

Do not use Femoston Conti if you have a history of breast cancer, blood clots, or liver disease. It is important to discuss your medical history with your doctor before starting this medication.

Directions

Take one tablet daily with water, at the same time each day. It can be taken with or without food. Do not crush or chew the tablet.

Scientific Evidence

Studies have shown that hormone replacement therapy, including estradiol and dydrogesterone, can effectively manage menopausal symptoms and improve quality of life in postmenopausal women. Research published in the Journal of the American Medical Association has highlighted the benefits of hormone therapy in reducing the risk of osteoporosis and cardiovascular disease in menopausal women.

Additional Information

It is important to attend regular follow-up appointments with your healthcare provider while taking Femoston Conti to monitor your response to the treatment. If you experience any unusual symptoms or side effects, contact your doctor immediately.

Femoston Conti tablets combine estradiol and dydrogesterone to provide a comprehensive approach to hormone replacement therapy. Estradiol helps alleviate menopausal symptoms by replacing the estrogen that the body no longer produces, while dydrogesterone helps protect the uterus lining. This combination offers a well-rounded treatment option for postmenopausal women.

Clinical trials have demonstrated the efficacy and safety of Femoston Conti in managing menopausal symptoms. A study published in the European Journal of Obstetrics & Gynecology and Reproductive Biology found that Femoston Conti effectively reduced the frequency and severity of hot flashes and night sweats in menopausal women, leading to an improved quality of life.